Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.140
+0.050 (1.22%)
At close: May 27, 2026, 4:00 PM EDT
4.140
0.00 (0.00%)
After-hours: May 27, 2026, 5:41 PM EDT
Opus Genetics Employees
As of December 31, 2025, Opus Genetics had 28 total employees, including 27 full-time and 1 part-time employees. The number of employees increased by 10 or 55.56% compared to the previous year.
Employees
28
Change (1Y)
10
Growth (1Y)
55.56%
Revenue / Employee
$427,964
Profits / Employee
-$3,819,000
Market Cap
295.61M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 28 | 10 | 55.56% | 27 | 1 |
| Dec 31, 2024 | 18 | 4 | 28.57% | 18 | 0 |
| Dec 31, 2023 | 14 | 5 | 55.56% | 14 | 0 |
| Dec 31, 2022 | 9 | 1 | 12.50% | 9 | 0 |
| Dec 31, 2021 | 8 | 3 | 60.00% | 8 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Cellectis | 229 |
| Fate Therapeutics | 161 |
| AC Immune | 122 |
| Zentalis Pharmaceuticals | 106 |
| Armata Pharmaceuticals | 61 |
| Protara Therapeutics | 46 |
| Surrozen | 44 |
IRD News
- 10 hours ago - Opus Genetics to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 1 day ago - Opus Genetics Touts Retinal Gene Therapy Pipeline, September BEST1 Data Catalyst - MarketBeat
- 6 days ago - Opus Genetics initiated with an Outperform at Leerink - TheFly
- 6 days ago - Opus Genetics initiated with an Outperform at Leerink - TheFly
- 8 days ago - Opus Genetics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 10 days ago - Opus Genetics Slides: Corporate presentation - Filings
- 14 days ago - Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference - GlobeNewsWire
- 14 days ago - Opus Genetics price target lowered to $11 from $12 at Citizens - TheFly